-transparent.png){kind=logo}
trans-Dihydrolisuride, a partial dopamine receptor agonist, was tested for its effects on chorea in a double-blind, crossover clinical study in 10 patients with Huntington's disease. In eight patients, a neurophysiological evaluation was also performed. No reduction in choreic movements or improvement in voluntary movement performance was observed. However, in some patients, there was a slight improvement in patients' alertness and a reduction of the movement reaction time.
Related Publications
F Stocchi, and
A Carta, and
A Berardelli, and
A Antonini, and
M Argenta, and
A Formica, and
A Agnoli
January 1987,
Advances in neurology,
F Stocchi, and
A Carta, and
A Berardelli, and
A Antonini, and
M Argenta, and
A Formica, and
A Agnoli
January 1992,
Psychiatry research,
F Stocchi, and
A Carta, and
A Berardelli, and
A Antonini, and
M Argenta, and
A Formica, and
A Agnoli
January 1995,
Functional neurology,
F Stocchi, and
A Carta, and
A Berardelli, and
A Antonini, and
M Argenta, and
A Formica, and
A Agnoli
April 1990,
Klinische Wochenschrift,
F Stocchi, and
A Carta, and
A Berardelli, and
A Antonini, and
M Argenta, and
A Formica, and
A Agnoli
January 1986,
European journal of clinical pharmacology,
F Stocchi, and
A Carta, and
A Berardelli, and
A Antonini, and
M Argenta, and
A Formica, and
A Agnoli
October 1991,
Clinical neuropharmacology,
F Stocchi, and
A Carta, and
A Berardelli, and
A Antonini, and
M Argenta, and
A Formica, and
A Agnoli
June 1992,
Neurology,
F Stocchi, and
A Carta, and
A Berardelli, and
A Antonini, and
M Argenta, and
A Formica, and
A Agnoli
January 2003,
CNS drugs,
F Stocchi, and
A Carta, and
A Berardelli, and
A Antonini, and
M Argenta, and
A Formica, and
A Agnoli
March 2018,
Ugeskrift for laeger,
F Stocchi, and
A Carta, and
A Berardelli, and
A Antonini, and
M Argenta, and
A Formica, and
A Agnoli
September 2019,
The New England journal of medicine,
